Annovis Bio, Inc. - Common Stock, $0.0001 par value per share (ANVS)

CUSIP: 03615A108

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+2,215,448
Put/Call ratio
45%
SEC-reported price per share
$3.46
Indexed holders
52
Value change
+$8,024,097
Number of buys
35
Open additional details 1 more signal available
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
44,920,581

Security key

03615A108

Report period

Q4 2025

Indexed institutions

52

Top holders

10

Ownership snapshot

Top reported holders of ANVS - Annovis Bio, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
CVI Investments, Inc.
Disclosed value leader
Maria-Luisa Maccecchini
Comparable rows
1/15
Latest evidence
28 Oct 2025
13D/G 3/4/5 13F Lead comparable stake: 4.9% 14 rows are not safely comparable across share classes. 13D/G row: CVI Investments, Inc. Showing 1-6 of 15 holder rows.

Quick read

CVI Investments, Inc. leads the comparable SEC ownership view at 4.9%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens CVI Investments, Inc.'s linked filing trail.
Comparable ownership Top 1
CVI Investments, Inc. 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
CVI Investments, Inc.
13D/G
4.9%
Reported 13D/G · 31 Mar 2025
$1,470,000
1,000,000 shares
$0 31 Mar 2025
Maria-Luisa Maccecchini
3/4/5
President & CEO, Director
—
denominator unverified
$2,484,641
1,212,020 shares
— 28 Oct 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,527,667
738,003 shares
— 30 Sep 2025
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
13F
—
denominator unverified
$452,131
218,421 shares
— 30 Sep 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$381,283
184,154 shares
— 30 Sep 2025
Mark K. White
3/4/5
Director
—
mixed-class rows
$373,119
81,167 shares
mixed-class rows
— 20 Nov 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
52
Shares
4,237,986
Indexed holders
52
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 indexed holders
42
Q4 2025 indexed holders
52
Indexed holder difference
10
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .